General Information
Revision date
2016-03-01
Product name
ORPHENADRINE CITRATE, USP
CAS No.
4682-36-4
1.2.1 Relevant identified uses
Skeletal muscle relaxant; antiparkinsonian; antihistaminic
supplier name
MEDISCA Inc
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
MEDISCA Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H336
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
HMIS Classification GHS CLASSIFICATION Acute Toxicity - Oral (Category 4) Specific Target Organ Toxicity - Single Exposure (Category 3) - Narcotic effects PICTOGRAM
Signal word
Warning HAZARD STATEMENT(S) Harmful if swallowed May cause drowsiness or dizziness AUSTRALIA-ONLY HAZARDS Not Applicable.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing, eye protection, face protection.
Response
IF SWALLOWED: Immediately call a poison center or medical professional. Rinse mouth. IF EXPOSED OR CONCERNED: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents and/or container in accordance with local regulations.
Health hazards
2 Flammability 0 Reactivity 0 Personal Protection E
2.1 Classification of the substance or mixture
Acute Toxicity - Oral (Category 4) Specific Target Organ Toxicity - Single Exposure (Category 3) - Narcotic effects PICTOGRAM SIGNAL WORD Warning HAZARD STATEMENT(S) Harmful if swallowed. May cause drowsiness or dizziness. AUSTRALIA-ONLY HAZARDS
